INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Recruiting · NCT02977780 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-08-19 | NCT02977780 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Accelerate Brain Cancer Cure | 2 |
| Celgene | 53 |
| David Reardon, MD | 2 |
| Eli Lilly and Company | 370 |
| Puma Biotechnology, Inc. | 11 |
| Quadriga Biosciences, Inc. | 2 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 558 |
| Columbia University Medical center | New York | United States | 224 |
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Huntsman Cancer Institute | Salt Lake City | United States | 107 |
| Lifespan / Rhode Island Hospital | Providence | United States | 2 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Mayo Clinic | Rochester | United States | 664 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| University of Pittsburgh Medical Center | Pittsburgh | United States | 63 |
| University of Virginia Health System | Charlottesville | United States | 57 |
| UT MD Anderson Cancer Center | Houston | United States | 204 |